Weight Gain and Belly Fat in Midlife: Why It Happens, and What Actually Helps

'My weight keeps climbing, and it is not coming off no matter how much I calorie restrict or exercise.'

Many Women tell me, 'I'm eating exactly what I ate at 35, and my body is responding completely differently.' Weight may settle around your middle for the first time. The same food and the same workouts that used to work may do nothing now, and you may be eating less and gaining anyway.

I spent decades eating low-fat, processed food and fearing fat. My body settled toward its own healthy set point once I began eating nutrient-dense fats and my thyroid medication was finally dialed in correctly.

Something else shifted for me too. As my own practices became more consistent, I noticed I craved more protein and fewer grains.

The more protein I ate, the more satiated I was, and my weight began to land back in my natural set point. It felt like attunement more than discipline: my practice helped me hear what my body was actually asking for.

What Can Be Behind It

Falling estrogen moves fat to your middle. Estrogen helps your cells respond to insulin and steers where your body stores fat. As it falls, storage shifts from your hips and thighs toward your belly, and the SWAN study found fat gain speeds up and lean muscle declines starting in the Menopause transition itself. 'What Is Actually Happening in Your Midlife Body' goes deeper, and 'Hormone Therapy 101' walks through your options.

Belly fat is active tissue. Fat stored deep around your organs releases inflammatory messengers of its own, so inflammation and belly weight feed each other. It also sends fatty acids to your liver, 1 road toward fatty liver. Go back to 'Inflammation: The Fire Under Everything, Where It Comes From, and the Damage It Does', and jump ahead to 'Your Liver, Your Kidneys, and Your Gut'.

Insulin resistance tells your body to store. Insulin is the key that lets sugar into your cells, and it is also a storage signal. When insulin stays high, your body is told to store fat and hold on to it, especially around your middle, however little you eat. 'Sugar, and the Addiction Nobody Names' shows how it builds, step by step.

Your thyroid sets the pace. T3 sets your resting metabolic rate, so hypothyroidism, Hashimoto's, or poor conversion of T4 to T3 lowers the energy you burn before you have moved at all. Weight with feeling cold, constipation, dry skin, and thinning hair points here. 'Your Thyroid, In Depth' goes deeper.

Cortisol and your adrenals. Cortisol releases sugar from your liver even when you have not eaten, which calls more insulin into your blood and drives belly fat. Each blood sugar crash asks your adrenals to rescue you. Read 'Cortisol and Midlife Burnout', 'Burnout and Fatigue', and 'Stress'.

Sleep. Short or broken sleep raises hunger and cravings the next day, and even 1 short night makes your body more insulin resistant. Night sweats and falling progesterone break sleep in these years. 'Sleep' shows you how to get it back.

Muscle loss. Muscle is where most of the sugar from a meal goes, so less muscle leaves more sugar in your blood and lowers the energy your body burns at rest. Dr. Gabrielle Lyon explains that low muscle mass can bring insulin resistance even in a lean Woman. The muscle sections of 'Aches, Stiffness, Frozen Shoulder, and Elbow Pain' go deeper.

Your gut. Weight gain with constipation and belching points toward methane-type SIBO, and methane slows the gut. A slow thyroid slows the gut too, and each feeds the other. Read 'SIBO' and 'The Gut, In Depth'.

Years of undereating. Severe calorie restriction reads to your body as scarcity, and scarcity pushes T4 toward Reverse T3, the brake, and away from T3, the gas. It also makes muscle harder to hold on to. 'Your Thyroid, In Depth' explains Reverse T3.

Medications and alcohol. Some antidepressants, beta blockers, and steroids can add weight, and so can several drinks a week. Weight that climbed after a new medication belongs in a conversation with your prescriber, and every decision about that medication stays with them. 'The Mimics' covers this.

Lipedema, a mimic. Fat that gathers evenly in both legs, hips, or arms, stops at your ankles or wrists, feels tender, and bruises easily points toward lipedema, which resists diet and exercise. 'The Mimics' describes how it is diagnosed.

What Helps

• Build a steady plate. 25 to 30 grams of protein at each of your 3 meals, vegetables first, and 6 to 15 different kinds of vegetables a day. 'Sugar, and the Addiction Nobody Names' shows how.
• Walk for 10 minutes after meals. Working muscles act like a sponge, soaking up glucose from your blood.
• Lift weights 2 to 3 times a week. 'Your Bones' has a sample week, and the joints chapter shows how to progress gradually.
• Leave 4 to 5 hours between meals, and keep total sugar under about 15 grams a day.
• Eat enough. Nutrient-dense fats and protein tell your body the scarcity is over.
• Protect your sleep and calm your Nervous System: inhale deep, exhale long. 'Sleep' and 'Stress' carry the full practice.
• Optimize your thyroid with your practitioner, and heal your gut. 'The Autoimmune Protocol' is the 90 days I wish every Woman in Midlife would do.
• Ask about hormone therapy. In the Women's Health Initiative, Women taking estrogen plus progestin had about 21 percent fewer new diagnoses of diabetes. 'Hormone Therapy 101' explains.
• Supplements, after testing. Berberine, myo-inositol, and magnesium, as 'Supplements' and the Sugar chapter describe.

GLP-1 Medications: What They Can Do, and What to Know First

GLP-1 is a hormone your gut releases after you eat. It tells your brain you are full, slows how fast your stomach empties, and helps insulin respond to a meal.

The medications copy that signal. Semaglutide is sold as Wegovy and Ozempic, and tirzepatide, which acts on GLP-1 and a second gut hormone called GIP, is sold as Zepbound and Mounjaro. For some Women, these medications are a real help, and the research behind them is strong.

What the trials show.

• STEP 1: 1,961 adults with overweight or obesity, 73 percent of them Women, took semaglutide or placebo for 68 weeks. Weight fell by an average of 14.9 percent on semaglutide and 2.4 percent on placebo, and about half the semaglutide group lost 15 percent or more.
• SURMOUNT-1: 2,539 adults took tirzepatide or placebo for 72 weeks. At the highest dose, weight fell by an average of 20.9 percent, compared with 3.1 percent on placebo.
• SELECT: 17,604 adults with heart disease and overweight, without diabetes, took semaglutide or placebo for about 3 years. Heart attacks, strokes, and cardiovascular deaths were 20 percent lower on semaglutide, 6.5 percent compared with 8.0 percent. About 28 percent of the participants were Women.

For a Woman carrying heart disease or diabetes risk, those numbers matter. Many skillful prescribers use these medications thoughtfully, and a Woman who chooses 1 with her prescriber deserves respect and good support.

The Functional Medicine questions are about what the medication asks of the rest of your body.

Your stomach and gut slow down. Slowing your stomach is part of how the medication works, and your gut feels it. In STEP 1, 44.2 percent of people on semaglutide had nausea, compared with 17.4 percent on placebo, and constipation reached 23.4 percent, compared with 9.5 percent.

The Wegovy prescribing information states it is not recommended for people with severe gastroparesis, lists postmarketing reports of ileus, intestinal obstruction, and severe constipation including fecal impaction, and notes rare reports of food entering the lungs during anesthesia. Tell your surgeon and anesthesia team you take a GLP-1 medication well before any procedure.

In a 2023 study in JAMA of health insurance records, people using a GLP-1 medication for weight loss had higher rates of pancreatitis, bowel obstruction, and gastroparesis than people using a different weight loss medication, bupropion-naltrexone. These events were rare, and an observational study shows association.

An already slow gut. My own methane measured about 75 ppm, and it climbed again while my thyroid was under-treated, because a slow thyroid slows the gut and a slow gut gives the methane makers time to settle back in. In my Functional Medicine view, adding a medication that slows digestion further to a gut already slowed by methane or a sluggish thyroid asks a great deal of that gut. That is my reasoning from how each piece works, so ask your prescriber and your gastroenterologist to weigh it with you, ideally with a breath test and a full thyroid panel in hand.

Dr. Mark Pimentel's concern. Dr. Mark Pimentel, the Cedars-Sinai gastroenterologist whose research tied IBS to bacterial overgrowth, teaches that 'any factor that slows down the speed of flow through the small intestine has the potential to cause overgrowth.' In a question and answer video with Dr. Allison Siebecker, 'Do Ozempic/Mounjaro cause SIBO? Or make SIBO worse?', he applies that teaching to GLP-1 medications, which slow the stomach and upper gut by design. His concern is that a slower gut gives bacteria more time to settle into the small intestine.

He also noted that the direct evidence was still early when he recorded it, and that eating less may mean less fermentation, so the effect on a Woman who already has SIBO may vary.

The first studies have begun to appear. In a 2025 analysis of global health records, people with type 2 diabetes who started a GLP-1 or GLP-1/GIP medication were about twice as likely to be diagnosed with SIBO within 12 months as people who started other diabetes medications, a difference that reached statistical significance only at 12 months. A 2025 Mayo Clinic study of 99 people on GLP-1 medications who were tested for overgrowth, with no comparison group, found SIBO and methane overgrowth common, and its authors noted that diabetes itself may be part of the picture.

Both studies are observational, and no trial has yet tested whether these medications cause SIBO. If you take a GLP-1 medication and new bloating or constipation appears, ask your prescriber about a breath test.

Muscle goes with the fat. In a STEP 1 body scan substudy, lean mass made up about 39 to 40 percent of the weight lost on semaglutide. In the SURMOUNT-1 body scan substudy of 160 adults, about 25 percent of the weight lost on tirzepatide was lean mass, and 75 percent was fat. Dr. Datis Kharrazian cautions that months of appetite suppression can shift the body toward breaking tissue down, which works against gut healing and Remission.

Your bones. In a 2024 trial of 64 adults at higher fracture risk, most of them postmenopausal Women, 52 weeks of semaglutide raised a marker of bone breakdown and lowered bone density at the spine and total hip compared with placebo. The authors pointed to the weight loss itself. In a 2024 JAMA Network Open trial, liraglutide alone lowered bone density more than exercise alone despite similar weight loss, and the combination of exercise and the medication preserved bone best.

What you eat when you barely want to eat. In 2025, the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society issued a joint advisory calling for adequate protein, strength training, and prevention of nutrient deficiencies in people on these medications. As 'Hair Loss, Skin, and Nails' explains, GLP-1 medications have been linked with higher odds of hair loss, and protein and ferritin are 2 of the most protective steps.

Weight returns after stopping. In the STEP 1 extension, 327 people were followed for a year after stopping semaglutide. They had lost 17.3 percent of their weight and regained roughly 2 of every 3 pounds they had lost, leaving a net loss of 5.6 percent, and most of their heart and blood sugar improvements drifted back toward where they started.

Gallbladder and pancreas. In STEP 1, gallbladder problems occurred in 2.6 percent on semaglutide and 1.2 percent on placebo, and acute pancreatitis in 0.2 percent, 3 people, and none on placebo. In SELECT, pancreatitis rates were similar in both groups, and the Wegovy label warns of acute pancreatitis. 'Your Liver, Your Kidneys, and Your Gut' explains why rapid weight loss thickens bile.

Your thyroid and the label. The medications carry a boxed warning because semaglutide caused thyroid C-cell tumors in rodents, and they are not used in people with a personal or family history of medullary thyroid cancer or MEN 2. Bring your full thyroid history to your prescriber.

Cost, and how long. As listed in 2026, list prices ran about $1,349 a month for Wegovy and $1,086 for Zepbound, with lower self-pay programs that change often. Since weight tends to return after stopping, many Women are prescribed these medications for years. In SELECT, 17 percent on semaglutide stopped because of side effects, compared with 8 percent on placebo.

My view, as a Functional Medicine educator. I believe many Women may not need a GLP-1 medication once their thyroid, adrenals, gut, blood sugar, and sleep are truly addressed. Test first, find your threads, and then decide with your prescriber whether a medication belongs in your plan. This is education to bring into that conversation, and every decision about starting, dosing, or stopping stays with your prescriber.

If you and your prescriber choose a GLP-1 medication, protect your muscle and your gut.

• Protein at every meal, 25 to 30 grams, even when your appetite is quiet.
• Strength training 2 to 3 times a week, and a DEXA scan to track muscle and bone.
• Some healthy fat at each meal, so your gallbladder keeps squeezing.
• Watch your bowels. Constipation is a signal to bring to your prescriber, especially with methane or a slow thyroid.
• Check ferritin and your full thyroid panel along the way.

'Protecting Your Muscle on a GLP-1 Medication', in 'Aches, Stiffness, Frozen Shoulder, and Elbow Pain', goes deeper.